The pharynx is an important part of the planarian anatomy, serving as the center of its body and an indication of a region of regeneration. Just like the pharynx, it serves many functions in discovering and understanding regenerative science through a model organism, which has been crucial for collecting data thus far into my research. In understanding the purpose and functions of the pharynx, an analysis of conducting pre-trials and beginning experimental trials will be the main focus of understanding the properties and potentials of ectoine (ECT) in regenerative medicine.
Data Collected
The main purpose of conducting pre-trials was to test the mortality rate, or in other words, the death rate of the Planarians when exposed to different concentrations of ectoine (ECT). A total of 4 dosage concentrations were tested throughout pre-trials, with 5 planarians allocated to each concentration of 5%, 10%, 25%, and 50% ECT. A time frame of 7 days was used to observe the mortality rate, and all dosage concentrations of 5% - 25% had passed the mortality rate test with no deaths recorded. However, the 50% ECT dosage concentration had recorded a death rate of 40% (2 out of 5 planarians) in the allocated timeframe for pre-trials, indicating that a 50% dosage concentration is too high to test the regenerative properties on Planaria. Therefore, the 25% ECT dosage concentration will be used for the rest of the experimental trials moving forward.
After completing pre-trials, it was time to begin my journey into fully understanding the properties of ECT on planarian regeneration. I have already begun my first experimental trials, where I have allocated a time frame of 7 days to feed, incision, and measure 15 planarians per trial. Throughout each trial, the planarians will be fed with boiled eggs and given a minimum of a few hours to digest the food before incisioning and initial measuring of each planarian begins. In my case, after a day of a digestive period, the initial measurements of each Planaria were measured and recorded where they were given about 3-4 days until the next measurements were recorded. The final measurements were recorded at the 7 day mark from when the initial measurements were recorded, which so far, I have been able to complete final measurement of the control group of trial #1. Some significant patterns that I have seen thus far with planarian regeneration is that most have been able to regenerate eye spots by the 3 to 4 day mark from when initial measurements were taken, which is the main indication that regneeration has been successful in these model organisms.
The biggest challenge of this research process has been timing. With unexpected delays in the shipment of planaria for the rest of my experimental trials due to harsh weather conditions that took place from where the planarians will be shipped from, I had to reschedule my timeline to fit within the delays. This made it even more difficult to figure out the timing of when each trial will be completed for each group (both control and experimental) as this has delayed my trials by a week. While this unexpected delay was not intended to happen during the beginning of my experimental trials, I decided to readjust my timeline to conduct my experimental trials, while also fitting within the timeframe that all data must be collected by. Additionally, to combat further delaying trial #1 of my experiement, I decided to use the leftover planarians that have been originally ordered for pre-trials, and use that to start up trial #1 for my control group.
Conducting research through both pre-trials and experimental trials has brought many successes and challenges thus far. With unexpected delays to successfully finishing pre-trials and beginning experimental trials, this process has taught me the importance of knowing when to pivot when plans take a turn. Especially when delays are not intended and are tedious to work around, it is necessary to know what to do in times of uncertainty with timing.